These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1100 related items for PubMed ID: 11400148

  • 1. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
    Massi D, Franchi A, Sardi I, Magnelli L, Paglierani M, Borgognoni L, Maria Reali U, Santucci M.
    J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
    [Abstract] [Full Text] [Related]

  • 2. Expression of matrilysin (matrix metalloproteinase-7) in primary cutaneous and metastatic melanoma.
    Kawasaki K, Kawakami T, Watabe H, Itoh F, Mizoguchi M, Soma Y.
    Br J Dermatol; 2007 Apr; 156(4):613-9. PubMed ID: 17493064
    [Abstract] [Full Text] [Related]

  • 3. Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value.
    Väisänen A, Tuominen H, Kallioinen M, Turpeenniemi-Hujanen T.
    J Pathol; 1996 Nov; 180(3):283-9. PubMed ID: 8958806
    [Abstract] [Full Text] [Related]

  • 4. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB, Westphal JR, Zendman AJ, Becker JC, Ruiter DJ, van Muijen GN.
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immunohistochemical expression patterns of the microRNA-processing enzyme Dicer in cutaneous malignant melanomas, benign melanocytic nevi and dysplastic melanocytic nevi.
    Sand M, Gambichler T, Sand D, Altmeyer P, Stuecker M, Bechara FG.
    Eur J Dermatol; 2011 Jul; 21(1):18-21. PubMed ID: 21262599
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in human malignant melanoma and their relation to angiogenesis.
    Tu YT, Tao J, Liu YQ, Li Y, Huang CZ, Zhang XB, Lin Y.
    Clin Exp Dermatol; 2006 May; 31(3):413-8. PubMed ID: 16681591
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Diagnostic and prognostic role of galectin 3 expression in cutaneous melanoma.
    Abdou AG, Hammam MA, Farargy SE, Farag AG, El Shafey EN, Farouk S, Elnaidany NF.
    Am J Dermatopathol; 2010 Dec; 32(8):809-14. PubMed ID: 20885286
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Immunohistochemical analysis of the S100A1, S100B, CD44 and Bcl-2 antigens and the rate of cell proliferation assessed by Ki-67 antibody in benign and malignant melanocytic tumours.
    Sviatoha V, Tani E, Kleina R, Sperga M, Skoog L.
    Melanoma Res; 2010 Apr; 20(2):118-25. PubMed ID: 20042890
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.